Indirect Costs in Ambulatory Patients with HIV/AIDS in Spain
- 1 January 2003
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 21 (15) , 1113-1121
- https://doi.org/10.2165/00019053-200321150-00005
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The Cost Effectiveness of Combination Antiretroviral Therapy for HIV DiseaseNew England Journal of Medicine, 2001
- The Changing Economics of HIV CareAIDS Patient Care and STDs, 2001
- The cost of HIV treatment and care. A global review.2001
- Highly Active Antiretroviral TherapyPharmacoEconomics, 2001
- Evolución del número de personas infectadas por el virus de la inmunodeficiencia humana y de los casos de sida en España: 1980–1998Medicina Clinica, 2000
- La utilización de recursos sanitarios en pacientes infectados por el virus de la inmunodeficiencia humana: creación de una base de datos y obtención de resultados de costesGaceta Sanitaria, 2000
- The AIDS Epidemic — Considerations for the 21st CenturyNew England Journal of Medicine, 1999
- Cost effectiveness of highly active antiretroviral therapy in HIV-infected patientsAIDS, 1999
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998
- The willingness to pay for health changes, the human-capital approach and the external costsHealth Policy, 1996